50% of DOAC Doses are Inappropriate in Older Adults? On The Role of Appropriate Dosing
Anticoagulation Forum shared on LinkedIn:
”Did you know? Up to 50% of DOAC doses are inappropriate in older adults—with underdosing being more common than overdosing.
Underdosing can actually increase the risk of stroke, systemic embolism, and cardiovascular hospitalizations, without reducing bleed risk.
This new resource, Clinical Considerations: Anticoagulation Use in Older Adults, provides practical guidance on:
- Dosing best practices
- Managing fall risk
- Addressing modifiable bleeding risk factors
- Choosing the right anticoagulant through individualized, shared decision-making
Read the full resource here.
Then, test your knowledge with our Show You Know Quiz and see how your clinical decision-making stacks up.
This resource was made possible through our collaboration with the American Pharmacists Association (APhA), with support from an educational grant by the Bristol Myers Squibb and Pfizer Alliance.
Special thanks to our expert content developers and reviewers: Christina Bookwalter PharmD, MS MEd, BCPS, BCACP, Stacey Kaplon, PharmD, BCACP, Katie Meyer, PharmD, BCPS, BCGP, Amanda McFee Winans, PharmD, BCPS, CACP.”

Stay informed on the latets in the field of anticoagulation with Hemostasis Today.
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS
